share_log

Short Interest in Sysmex Co. (OTCMKTS:SSMXY) Decreases By 68.8%

Financial News Live ·  02/13/2023 07:41

Sysmex Co. (OTCMKTS:SSMXY – Get Rating) was the recipient of a significant drop in short interest in January. As of January 31st, there was short interest totalling 12,700 shares, a drop of 68.8% from the January 15th total of 40,700 shares. Based on an average daily volume of 47,500 shares, the short-interest ratio is currently 0.3 days.

Sysmex Stock Performance

Shares of SSMXY traded down $0.96 during trading hours on Friday, hitting $32.50. The company's stock had a trading volume of 11,659 shares, compared to its average volume of 19,857. The company has a market cap of $13.63 billion, a price-to-earnings ratio of 36.93 and a beta of 0.64. The company has a debt-to-equity ratio of 0.05, a current ratio of 2.88 and a quick ratio of 2.07. The business has a 50 day simple moving average of $31.61 and a two-hundred day simple moving average of $30.17. Sysmex has a 52-week low of $25.08 and a 52-week high of $47.57.

Get Sysmex alerts:

Sysmex (OTCMKTS:SSMXY – Get Rating) last posted its earnings results on Wednesday, November 9th. The company reported $0.28 earnings per share for the quarter. The firm had revenue of $782.19 million during the quarter. Sysmex had a net margin of 11.70% and a return on equity of 12.51%. On average, equities analysts expect that Sysmex will post 0.92 earnings per share for the current fiscal year.

About Sysmex

(Get Rating)

Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing.

Featured Articles

  • Get a free copy of the StockNews.com research report on Sysmex (SSMXY)
  • MarketBeat Week in Review – 2/6 – 2/10
  • Will Snowflake Have Tough Sledding, Trying To Keep Rally Alive?
  • The Bottom Is In For Cloudflare Stock
  • 3 Tickers Leading a Meme Stock Revival
  • Microsoft-Activision Blizzard Merger: Navigating Risk and Reward

Receive News & Ratings for Sysmex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sysmex and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment